COMBINING ANDROGEN DEPRIVATION AND IMMUNOTHERAPY TO PREVENT PROGRESSION TO CASTRATION-RESISTANT PROSTATE CANCER

$1,022,588FY2019Defense Health AgencyDOD

Health Research, Inc., Rockville MD

Investigators